Lorenzo Piemonti

This inventor holds 3 USPTO granted patents and 4 published patent applications, plus 2 CIPO patents and 2 EPO patents. Top assignees: Dompé Farmaceutici S.p.a., Dompe S.p.a., Dompe' Farmaceutici Spa. Active years: 2014-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lorenzo Piemonti. Retrieved from https://idiyas.com/inventor/lorenzo-piemonti

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 (Patent Applications = 4)

% Patents Active = 100.0

CIPO Patents = 2 (Patent Applications = 2)

EPO Patents = 2 (Patent Applications = 9)

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 2(Granted Patents)

Company Filing History:

1 out of 55

Dompé Farmaceutici S.p.a.

Dompe' Farmaceutici Spa

patent

Years Active: 2014-2026

Loading Chart...

3 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12636268 - CXCL8 inhibitors for use in the treatment of COVID-19 (2026-05-26),

2. 9556115 - Sulfonamides for the prevention of diabetes (2017-01-31),

3. 8846755 - Sulfonamides for the prevention of diabetes (2014-09-30),

Title: Lorenzo Piemonti: Innovator in Diabetes Prevention

Introduction

Lorenzo Piemonti is a notable inventor based in Milan, Italy. He has made significant contributions to the field of medicine, particularly in the prevention of diabetes. With a total of 3 patents, his work has the potential to impact many lives.

Latest Patents

Piemonti's latest patents focus on sulfonamides for the prevention of diabetes. The first patent discloses the use of sulfonamides of formula (I), wherein R and R are defined in the description, for the preparation of medicaments aimed at preventing diabetes, specifically type-1 diabetes. This innovative approach highlights the importance of early intervention in diabetes management.

Career Highlights

Throughout his career, Lorenzo Piemonti has worked with prominent companies such as Dompé S.p.a. and Dompé Farmaceutici S.p.a. His experience in these organizations has allowed him to develop and refine his innovative ideas in the pharmaceutical industry.

Collaborations

Piemonti has collaborated with notable colleagues, including Luisa Daffonchio and Marcello Allegretti. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Lorenzo Piemonti's work in the field of diabetes prevention through innovative sulfonamides showcases his dedication to improving health outcomes. His contributions are a testament to the impact of research and innovation in medicine.

Profile summary based on public USPTO records.